Viatris is working diligently to strengthen our position as a trusted partner in the collective efforts to improve global health and wellbeing. The world is experiencing significant challenges in the pursuit to build a more sustainable and inclusive future for everyone. As a signatory to the U.N. Global Compact, we believe companies can be important partners in the concerted work required to address many of these persistent, global challenges.
Access is at the core of our mission and our work to build more resilient healthcare systems and uphold a reliable global supply of medicines. As a global healthcare company with an exceptionally broad and diverse portfolio and global reach, our most significant contribution to society is building access to medicine and partnering for more resilient healthcare systems. However, it is not only about what we do, but also how we do it.
1The number of patients served is an estimate calculated using internal sales data (global volume of doses sold in 2025 in all markets as aligned with IQVIA standard units), divided by estimated per patient usage, which is based on treatment dose, treatment duration, and treatment adherence as estimated by Viatris Medical Affairs based on approved label indication and instructions for use, current international guideline recommendations, and common usage in clinical practice. Patients using multiple Viatris medicines may be counted as multiple patients. Certain adjustments were applied to account for acceptable alternatives to the patient usage factors noted above and rounded to the nearest hundred million. Estimates may be subject to reassessment.
